Skip to main content

Hull Hans's Form 4 filing

Pliant Therapeutics, Inc. (PLRX) · filed Aug 7, 2023

Accession no.
0001209191-23-044892
Filed
Aug 7, 2023
Trade date
Aug 3-4, 2023
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $698.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hull HansCIK 0001614876Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 3, 2023Common StockSSaleDisposed−13,069$20.00−$261,380206,114Direct
Aug 3, 2023Common StockMOption exerciseAcquired+1,800$2.08+$3,744207,914Direct
Aug 3, 2023Common StockSSaleAcquired+1,800$20.00+$36,000206,114Direct
Aug 4, 2023Common StockMOption exerciseAcquired+8,791$2.08+$18,285.28214,905Direct
Aug 4, 2023Common StockSSaleDisposed−20,050$20.01−$401,200.5194,855Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 3, 2023Common StockMOption exerciseDisposed−1,800$0.00$040,158Direct
Aug 4, 2023Common StockMOption exerciseDisposed−8,791$0.00$031,367Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)